The Bowman-Birk inhibitor-polyester conjugate: Synthesis, inhibition of serine proteinases, and suppression of radiation transformation in vitro

N. I. Larionova, I. N. Topchieva, I. P. Gladysheva, A. R. Kennedy

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The Bowman-Birk soybean inhibitor (BBI) was modified by the monoaldehyde derivative of block copolymer of ethylene oxide and propylene oxide, Mr 2000. This copolymer is capable of pentrating through biological membranes. The conjugate contained five covalently bound polymer chains per protein molecule. The modified BBI retained the capacity for effective inhibition of α-chymotrypsin (K(i) = 4.0 x 10-8 M) and human leukocyte elastase (K(i) = 1.2 x 10-7 M). BBI-conjugate, like purified BBI, suppressed radiation transformation in vitro.

Original languageEnglish (US)
Pages (from-to)158-163
Number of pages6
JournalCancer Journal
Volume7
Issue number4
StatePublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The Bowman-Birk inhibitor-polyester conjugate: Synthesis, inhibition of serine proteinases, and suppression of radiation transformation in vitro'. Together they form a unique fingerprint.

Cite this